Orphan Drug Act

These smaller population “Orphan Diseases,” defined as those that affect less than 200,000 people across the U.S., collectively impact 25 million Americans. This substantial public health issue warrants Lancet's call-to-action.
It is Game On!  for President Trump appointee Scott Gottlieb, the commissioner of the Food and Drug Administration. Things are definitely changing there, and at this point, it's a pretty good start.